Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
MabPharm (2181 HK)
Watchlist
14
Analysis
Health Care
•
China
Mabpharm Limitied manufactures medical products. The Company produces cancer treatment drugs, immune diseases drugs, biosimilar drugs, and other products. Mabpharm markets its products throughout China.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
10 Jul 2024 20:11
List Of Directors And Their Roles And Functions
Attachment
Exchange Announcement •
10 Jul 2024 20:08
(1) Appointment Of Non-Executive Director And Independent Non-Executive Director (2) Re-Designation Of Non-Executive Director And (3) Appointment Of Vice Presidents
Attachment
Exchange Announcement •
02 Jul 2024 18:09
Inside Information Announcement Approval From The Ministry Of Health Of Peru On The New Drug Application (Nda) Of Our Core Product, Cmab008 (Infliximab For Injection)
Attachment
Exchange Announcement •
25 Jun 2024 16:58
Inside Information Announcement Approval From The National Medical Products Administration On The New Drug Application (Nda) Of Our Core Product, Cmab009 (Cetuximab Beta Injection)
Attachment
Exchange Announcement •
21 Jun 2024 17:29
Poll Results Of The Annual General Meeting Held On Friday, 21 June 2024
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x